 Expanded Clinical Evaluation Lovastatin EXCEL study results Efficacy plasma lipoproteins adverse event profile patients moderate hypercholesterolemia Expanded Clinical Evaluation Lovastatin EXCEL Study multicenter double-blind diet- placebo-controlled trial efficacy safety lovastatin patients moderate hypercholesterolemia Patients placebo lovastatin dosage mg mg daily mg mg weeks Lovastatin dose-related dosages mg/d low-density lipoprotein-cholesterol level high-density lipoprotein-cholesterol level total cholesterol level triglyceride level National Cholesterol Education Program low-density lipoprotein-cholesterol level goal mmol/L mg/dL patients mmol/L mg/dL goal patients difference lovastatin placebo incidence clinical adverse experiences discontinuation small mg mg/d Successive transaminase level elevations times upper limit normal patients placebo mg/d lovastatin mg/d mg/d lovastatin trend Myopathy muscle symptoms creatine kinase elevation times upper limit normal patient mg daily patients mg/d lovastatin lovastatin adequate trial prudent diet effective well-tolerated treatment patients moderate hypercholesterolemia